CN1843460A - Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method - Google Patents
Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method Download PDFInfo
- Publication number
- CN1843460A CN1843460A CN 200510085788 CN200510085788A CN1843460A CN 1843460 A CN1843460 A CN 1843460A CN 200510085788 CN200510085788 CN 200510085788 CN 200510085788 A CN200510085788 A CN 200510085788A CN 1843460 A CN1843460 A CN 1843460A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- medicine
- fructus
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036772 blood pressure Effects 0.000 title claims abstract description 8
- 230000004089 microcirculation Effects 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 title claims description 40
- 210000004369 blood Anatomy 0.000 title claims description 28
- 239000008280 blood Substances 0.000 title claims description 28
- 230000001603 reducing effect Effects 0.000 title claims description 9
- 229940079593 drug Drugs 0.000 title claims description 5
- 230000036039 immunity Effects 0.000 title description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 230000017531 blood circulation Effects 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 238000009472 formulation Methods 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 7
- 239000000341 volatile oil Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 230000006872 improvement Effects 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000007796 conventional method Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000011812 mixed powder Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 241000219780 Pueraria Species 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 230000036737 immune function Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000201320 Ligustrum japonicum Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
- 238000012360 testing method Methods 0.000 description 13
- 206010012601 diabetes mellitus Diseases 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- 229940125396 insulin Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 208000017442 Retinal disease Diseases 0.000 description 4
- 206010038923 Retinopathy Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- -1 iodine ureas Chemical class 0.000 description 4
- 235000007586 terpenes Nutrition 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 2
- 229960002297 fenofibrate Drugs 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000008336 microcirculatory blood flow Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047073 Vascular fragility Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000000207 lymphocyte subset Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 229940125395 oral insulin Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Case load | Insulin dosage (U/d) | Diamicron consumption (mg/d) | Fasting glucose decline (mmol/L) | |||
Before | After | Before | After | Before | After | |
Test group 100 matched groups 50 T P | 46.2 45.89 0.28 >0.05 | 20.59 49.18 10.87 <0.01 | 260 240 0.26 >0.05 | 60 280 8.75 <0.01 | 11.7±3.69 11.37±3.18 0.54 >0.05 | 7.55±2.32 9.78±3.01 2.46 <0.01 |
Case load | Fenofibrate consumption (U/d) | Serum cholesterol meansigma methods (mg/d) | Serum glycerol meansigma methods (mmol/L) | |||
Before | After | Before | After | Before | After | |
Test group 100 | 0 | 0 | 5.77±1.10 | 4.52±0.82 | 2.12±1.07 | 1.34±0.53 |
Matched group 50 T P | 300 | 300 | 5.87±1.06 0.84 >0.05 | 5.13±0.97 4.32 >0.01 | 2.08±0.93 0.76 >0.05 | 2.51±0.32 3.55 >0.05 |
The example number | OKT(%) | OKT 4(%) | OKT 3(%) | OKT 4 OKT 3 | ||
Test group | Before the treatment | 50 | 64.47±6.23 | 36.47±4.27 | 31.48±3.68 | 1.27±0.14 |
Before the treatment | 50 | 64.37±7.28 | 38.91±4.12 | 27.57±4.32 | 1.43±0.32 | |
Matched group | 40 | 64.36±8.70 | 38.91±4.11 | 25.43±4.18 | 1.46±0.24 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100857881A CN100488546C (en) | 2005-08-16 | 2005-08-16 | Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100857881A CN100488546C (en) | 2005-08-16 | 2005-08-16 | Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1843460A true CN1843460A (en) | 2006-10-11 |
CN100488546C CN100488546C (en) | 2009-05-20 |
Family
ID=37062446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100857881A Expired - Fee Related CN100488546C (en) | 2005-08-16 | 2005-08-16 | Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100488546C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721187A (en) * | 2013-12-20 | 2014-04-16 | 安徽金太阳生化药业有限公司 | Blood-circulation-promoting and blood-fat-reducing pill for treating hyperlipemia and preparation method of pill |
CN105250494A (en) * | 2015-10-30 | 2016-01-20 | 华北理工大学 | Traditional Chinese medicine recipe for improving glycometabolism and preparation process |
CN106214922A (en) * | 2016-08-26 | 2016-12-14 | 吕晶晶 | A kind of Chinese medicine composition treating hypertension and preparation method thereof |
-
2005
- 2005-08-16 CN CNB2005100857881A patent/CN100488546C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721187A (en) * | 2013-12-20 | 2014-04-16 | 安徽金太阳生化药业有限公司 | Blood-circulation-promoting and blood-fat-reducing pill for treating hyperlipemia and preparation method of pill |
CN105250494A (en) * | 2015-10-30 | 2016-01-20 | 华北理工大学 | Traditional Chinese medicine recipe for improving glycometabolism and preparation process |
CN106214922A (en) * | 2016-08-26 | 2016-12-14 | 吕晶晶 | A kind of Chinese medicine composition treating hypertension and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN100488546C (en) | 2009-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
CN108404062B (en) | Traditional Chinese medicine composition for treating hyperlipidemia and preparation method and application thereof | |
CN1839944A (en) | Granular composition for reducing blood fat and process for producing the same | |
CN1939506B (en) | Preparation with blood-pressure, blood-sugar and blood-fat lowering functions and its making method | |
CN1853702A (en) | Chinese medicinal preparation for lowering blood sugar, blood fat and blood pressure, improving blood flow and immune and its making method | |
CN101496894B (en) | Medicament for treating fatty liver and preparation method thereof | |
CN100488546C (en) | Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method | |
CN1857599A (en) | Medicine for lowering blood sugar, blood fat and blood pressure, raising blood flow rate and raising immunity and its preparing method | |
CN102178733A (en) | Chinese medicinal preparation for treating diabetes and preparation method thereof | |
CN1149097C (en) | Chinese patent medicine for curing diabetes | |
CN1957972A (en) | Composition in use for invigorating primordial energy, benefiting pubic region, preparation method and usage | |
CN1256967C (en) | Health-preserving liver-protecting drug and method for making same | |
CN101041037A (en) | Drug for curing diabetes and nephropathy and its preparing method | |
CN1430982A (en) | Capsule of astragalus and honey as well as its preparing technique | |
CN1857605A (en) | Medicine for treating chronic alcoholic hepatopathy and its preparing method | |
CN1272054C (en) | Medicine for treating diabetes and its preparing process | |
CN1063649C (en) | Red ginseng and hawthorn fruit health-care wine | |
CN1183936C (en) | Medicine for treating hypertension and method for preparing medicinal tea thereof | |
CN111000969A (en) | Pharmaceutical composition for treating simple obesity and preparation method thereof | |
CN100337639C (en) | Concentrated life-cultivating blood-sugar reducing beverge | |
CN100339119C (en) | Traditional Chinese medicine prepns. for treating diabete | |
CN102614271A (en) | Chinese medicine for treating diabetic dyslipidemia | |
CN1097333A (en) | A kind of pure plant health preparation glycolipid disappears and method for making | |
CN1279961C (en) | Chinese prepared drug formulation for stopping cough and eliminating sputum and its preparation process | |
CN102078562B (en) | Chinese medicinal oral liquid for treating children metabolic syndrome and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING HONG SENG MEDICINE SCIENCE AND TECHNOLOGY Free format text: FORMER OWNER: YANG JIXING Effective date: 20091225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091225 Address after: Beijing Daxing District biomedical industry base, 9 Fu Tian street, No. 12, building Patentee after: Beijing Gangsheng Pharmaceutical Technology Co., Ltd. Address before: Shanxi City Development Zone in Linfen province river Fen road Qimao City Huagang Patentee before: Yang Jixing |
|
DD01 | Delivery of document by public notice |
Addressee: Yang Jixing Document name: Notification to Pay the Fees |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090520 Termination date: 20130816 |